SOHO 4th Italian Conference

www.sohoitaly.com

 

SOHO 4th Italian Conference
G

SOHO Italy 2022: Phase 3 SELECT-MDS-1 Study - A Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene + Aza vs. Placebo + Aza in Newly Diagnosed Adult Patients Selected for RARA+ HR-MDS

By SOHO 4th Italian Conference FEATURING Giovanni Marconi
By SOHO 4th Italian Conference FEATURING Giovanni Marconi
42 views
November 28, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
MDS and MPN
08:27

SOHO Italy 2022: Epigenetic Changes in MDS-Derived Mesenchymal Strom…

SOHO 4th Italian Conference

S. Giallongo

12 views
20:30

SOHO Italy 2022: Treatment of HR-MDS in 2022 at MDACC

SOHO 4th Italian Conference

G. Garcia-Manero

59 views
06:12

SOHO Italy 2022: Phase 3 SELECT-MDS-1 Study - A Randomized, Double-B…

SOHO 4th Italian Conference

G. Marconi

42 views
13:27

SOHO Italy 2022: How I Treat MF Candidates for Transplant

SOHO 4th Italian Conference

N. Polverelli

60 views
10:38

SOHO Italy 2022: Essential Thrombocythemia

SOHO 4th Italian Conference

A. Tefferi

313 views